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A B S T R A C T
Background: Endomyocardial Biopsy (EMB) is the gold standard test for diagnosis of 
acute allograft cardiac rejection.
Objectives: The present study aimed to assess the role of echocardiographic parameters 
in discriminating patients with and without evidence of acute cardiac allograft rejection.
Materials and Methods: In the present cross-sectional study, using convenience 
sampling, 63 EMB specimens were collected from the patients who had undergone 
biatrial orthotropic cardiac transplantation. The mean age of the recipients and donors 
was 30.46 ± 9.49 and 24.55 ± 7.64 years, respectively. There were 51(81%) male recipients 
and 39(62%) male donors. Echocardiographic examination was performed within the 24 
hours of EMB. The data were entered into the SPSS statistical software, version 19 and 
were analyzed by chi-square test, student’s t-test, and one-way ANOVA as appropriated. 
All the data were two-tailed and P < 0.05 was considered to be statistically significant.
Results: Among the 63 EMB specimens evaluated in the present study, mild and 
moderate acute rejections were seen in 19(30%) and 5(8%) cases, respectively. On Doppler 
examination, the three groups (without rejection, with mild rejection, and with moderate 
acute rejection) were significantly different only regarding trans-tricuspid E wave (P = 
0.040). Pulsed-wave Tissue Doppler Imaging (TDI) also revealed a significant difference 
between the patients with and without allograft rejection regarding early diastolic 
tricuspid and mitral annular motion velocities (P = 0.005 and P = 0.02, respectively).
Conclusions: It seems that echocardiographic parameters, including TDI, might 
be adjunct to, rather than substitution for, EMB findings for early diagnosis of acute 
allograft rejection.
*Corresponding author: Sepideh Taghavi, Vali-Asr Ave., Niyayesh Blvd., Rajaei 
Cardiovascular Medical and Research Center, Iran University of Medical 
Sciences, Tehran, Iran. Zip code: 199691-1151, Tel/Fax: +98-2123921, 
E-mail: sepide1349@yahoo.com
1. Background
Cardiac transplantation is considered to be a life-saving 
treatment option for patients with end-stage heart failure. 
However, rejection occurs in most patients. Cardiac allograft 
rejection is classified into three major categories, namely 
hyperacute, acute, and chronic. Hyperacute rejection 
occurs within minutes to hours after transplantation and 
►Implication for health policy/practice/research/medical education:
Cardiac transplantation is a life-saving treatment option for patients with end-stage heart failure. Despite advanced immunosuppressive regimes, 
acute cardiac allograft rejection is still the major cause of morbidity and mortality in the first year post-transplantation. Identification of patients at 
an earlier stage would prevent progression to more severe disease and ultimately reduces the risk of long-term complications. In the present study, 
we assessed the clinical applicability of tissue Doppler imaging techniques in the early diagnosis of acute cardiac allograft rejection.
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is caused by preexisting antibodies to allogenic antigens. 
Acute rejection is classified into acute cellular rejection 
(or cell-mediated rejection) and acute humoral rejection 
(or antibody-mediated rejection). Acute cellular rejection 
most commonly occurs within the first weeks to several 
years after transplantation. Finally, chronic rejection 
occurs within months to years after transplantation. 
Despite advanced immunosuppressive regimes, Acute 
Cardiac Allograft Rejection (ACAR), with an incidence 
rate of over 40%, is still the major cause of morbidity and 
mortality in the first year post-transplantation (1). Clinical 
features of allograft rejection are unreliable and most 
patients often remain asymptomatic until hemodynamic 
complications ensue (2). Routine screening is therefore 
performed at fixed schedules to detect allograft rejection. 
Identification of patients at an earlier stage followed by early 
immunosuppressive therapy would prevent progression 
to more severe disease and ultimately reduces the risk of 
long-term complications. Right ventricular Endomyocardial 
Biopsy (EMB) and histological evaluation of the myocardial 
tissue constitute the gold standard surveillance tool after 
cardiac transplantation (3, 4). However, this procedure 
is invasive, expensive, and time-consuming. Moreover, 
due to sampling errors related to the patchy nature of 
allograft rejection as well as inter-observer variability in 
the interpretation of histological findings, ‘biopsy-negative’ 
rejection occurs in up to 20% of patients (5). Uncommon 
but potentially serious complications, such as tricuspid 
valve insufficiency, coronary artery-right ventricular 
fistula, carotid artery puncture, arrhythmia, and prolonged 
bleeding, may also occur (4, 6-9).
Extensive studies have attempted to develop a non-
invasive diagnostic tool to screen patients at risk of acute 
allograft rejection. An accurate and non-invasive method 
with desirable patient comfort, risk, convenience, speed, 
and cost can eliminate or decrease the need for serial EMB. 
However, data are still insufficient and conflicting regarding 
the role of echocardiography in detection of ACAR.
2. Objectives
The present study aims to evaluate the clinical applicability 
of systolic and diastolic echocardiographic indices, 
particularly Tissue Doppler Imaging (TDI) techniques, in 
early diagnosis of ACAR.
3. Materials and Methods
After gaining the approval of the institutional Ethics 
Committee and obtaining written informed consents, 
using convenience sampling, 63 EMB specimens were 
obtained from heart transplant recipients to be included in 
the present cross-sectional study. All the required data were 
collected via a paper-based questionnaire completed by one 
of the investigators (MA). Right ventricular myocardial 
biopsy using International Society of Heart and Lung 
Transplantation (ISHLT) 2005 grading system was used 
as the gold standard test for diagnosis of acute myocardial 
rejection (10).
3.1. Patients
All the patients undergoing orthotopic cardiac 
transplantation at Rajaei Cardiovascular Medical and 
Research Center, Imam Khomeini hospital, and Shariati 
Hospital, Tehran, Iran during 2008 - 2011 were consecutively 
enrolled into the present study. The patients who had post-
transplant valvular prostheses, re-transplantation, and 
insufficient imaging quality for analysis were excluded 
from the study.
3.2. Cardiac Transplantation
All the heart transplantations were performed by a single 
team with one surgeon through Biatrial (BA) orthotopic 
heart transplant surgical technique. The BA technique 
was performed as described by Lower and Shumway 
(11). Donor heart preservation consisted of hypothermic 
cardioplegic arrest and storage at 4°C after perfusion with 
Stanford solution.
3.3. Cardiac Catheterization and Endomyocardial Biopsy
As per institutional policy, acute rejection is monitored 
by serial myocardial biopsies started from day 14 post-
transplantation and performed weekly during the first 
month, every 2 weeks in the second and third months, 
monthly until the 6th month, every 3 months until the end 
of the second year, and at 6-month intervals thereafter. A 
myocardial biopsy was also obtained whenever clinical 
suspicion of transplant rejection was present.
Right-side catheterization was performed using standard 
internal jugular venous approach. After inserting a 7-9F 
sheath in the right internal jugular vein, the bioptome was 
guided through the tricuspid valve into the right ventricle. 
Four to eight samples were taken at each catheterization from 
the mid-portion of the interventricular septum. Afterwards, 
the samples were immediately fixed in formaldehyde and 
were sent to the pathology laboratory.
3.4. Pathological Evaluations
The specimens were embedded in paraffin and hematoxylin-
eosin dye was used to examine the tissue samples. All the 
biopsies were read by a single experienced pathologist who 
was blinded to the cardiac echocardiographic findings. 
Cellular rejection was graded according to the revised 
2005 ISHLT grading system as follows: grade 0R biopsies 
were considered as negative for cellular rejection, grade 1R 
biopsies as mild cellular rejection, grade 2R as moderate 
cellular rejection, and grade 3R biopsies as severe cellular 
rejection (10).
3.5. Echocardiography
A conventional transthoracic echocardiographic 
examination together with acquisition of myocardial 
velocity imaging was performed on each patient within 24 
hours of the biopsy procedure using a Vivid 7 ultrasound 
system (GE Medical System, Horton, Norway) and a 1.7/3.4 
MHz transducer. All the echocardiographic studies were 
performed by a single echocardiographist who was totally 
blinded to the pathology results.
3.6. Standard Echocardiography
Left Ventricular (LV) M-mode measurements included 
septal and posterior wall thickness at end diastole, 
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interventricular septum, and right ventricular free wall all 
measured from an apical four-chamber view. LV volume 
and Ejection Fraction (EF) were measured using Simpson’s 
method through apical two- and four-chamber views. In 
addition, left and right ventricular fillings were assessed 
by measuring inflow at the tips of the leaflets of the mitral 
and tricuspid valves using pulsed Doppler. The following 
parameters were measured: early diastolic peak flow 
velocity (E, cm/s), late diastolic velocity (A, cm/s), and time 
to E-wave (measured from the beginning of the QRS to the 
peak E wave, msec). The Myocardial Performance Index 
(MPI), also known as Tei index, was calculated using the 
following formula:
(IVCT, isovolumic contraction time; IVRT, isovolumic 
relaxation time; ET, ejection time).
3.7. Tissue Doppler Myocardial Imaging
Longitudinal myocardial velocity profiles were obtained 
from the 4-chamber left apical view. Peak systolic (Sm), 
early diastolic (Em), and late diastolic (Am) velocities were 
measured off-line at the base and middle segments of the 
septum, LV lateral wall, and right ventricular free (lateral) 
wall by Pulsed-Wave Tissue Velocity Imaging (PW-TVI) 
and Color-Coded Tissue Velocity Imaging (CD-TVI).
3.8. Immunosuppressive Regimen
All the patients received Intravenous (IV) administration 
of l000 mg methylprednisolone during the operation. 
Methylprednisolone (250 mg per day) was also given 
intravenously in two divided doses in the first 2 days after 
the operation followed by 1 mg. kg-1 oral prednisolone 
thereafter. Prednisolone was tapered by 5 mg until reaching 
the dose of 15 mg per day, which was continued for at least 
one year later. Besides, 1000 mg mycophenolate mofetil 
(CellCept®) was administered prior to the operation and 
was continued as 1000 mg twice a day lifelong. Moreover, 
100 mg rabbit Anti-Thymocyte Globulin (ATG) per day 
was infused over 4-8 hours during the first 3 days post 
operation. Cyclosporine was also administered based on the 
serum level beginning from the second day post-operation 
and continuing lifelong.
3.9. Data Analysis
All the analyses were performed by Statistical Package for 
Social Sciences software, version 19 (SPSS Inc, Chicago, IL). 
All the values were expressed as mean ± SD for continuous 
variables and number (percentage) for categorical ones. 
Normality was evaluated for each variable on the basis 
of normal distribution plots and histograms and by 
Kolmogorov-Smirnov test. The two groups were compared 
regarding clinical characteristics and echocardiographic 
indices using chi-square test for categorical variables 
and student’s t-test, Mann-Whitney test, Kruskal-Wallis 
test, and one-way ANOVA for quantitative variables as 
appropriated. All the data were two-tailed and P < 0.05 was 
considered to be statistically significant.
4. Results
4.1. Patients’ Characteristics and Clinical Data
In total, 63 specimens were presented. The mean age of 
the recipients and donors was 30.46 ± 9.49 and 24.55 ± 7.64 
years, respectively. Besides, the mean follow-up period after 
orthotopic cardiac transplantation was 68.11 ± 62.15 weeks, 
ranging from 2 to 265 weeks.
Endomyocardial histopathology revealed ISHLT rejection 
grade 0 (no rejection) in 39 (61.9%), grade 1R (mild 
rejection) in 19 (31.16%), and grade 2R (moderate rejection) 
in 5 (7.93%) samples. No cases of ISHLT grade 3R were 
seen during the study period. Demographic characteristics 
of the group without ACAR (N = 39), the group with mild 
ACAR (N = 19), and the group with moderate ACAR (N = 
5) have been presented in Table 1.
4.2. Conventional Echocardiographic Data
The study groups’ conventional echocardiographic 
parameters based on the ISHLT grades have been show 
in Table 2. Accordingly, no significant differences were 
observed among the study groups in terms of conventional 
echocardiographic parameters.
Table 1. Demographic Characteristics of the Recipients and Donors
ISHLT Grading 2005
P valueNo rejection (Grade 0) 
N = 39
Mild rejection (Grade 1R) 
N = 19
Moderate rejection (Grade 2R) 
N = 5
Recipient’s age, yrs 29.6 ± 18.26 30.10 ± 11.57 38.40 ± 7.70 0.132
Recipient’s sex, n (%)
Male 32 (63) 14 (27) 5 (10)
0.273
Female 7 (59) 5 (41) (0)
Height, cm 168.84 ± 9.04 167.36 ± 13.53 172.60 ± 10.01 0.692
Weight, kg 68.98 ± 18.66 64.94 ± 16.93 79.20 ± 32.07 0.440
BMI, kg/m2 23.84 ± 5.05 23.10 ± 5.57 26.69 ± 4.96 0.401
BSA, m2 1.77 ± 0.25 1.72 ± 0.26 1.97 ± 0.29 0.312
Donor’s age, yrs 24.88 ± 7.36 22.73 ± 7.82 29.00 ± 6.86 0.155
Donor’s sex, n (%)
Male 25 (64) 10 (26) 4 (10)
0.075
Female 14 (59) 9 (37.5) 1 (4.5)
Time from HTx, weeks 32.5 (8.5 - 86.0) 42.0 (24.5 - 111.0) 56.0 (17.0 - 137.5) 0.385
Abbreviations: BMI, body mass index; BSA, body surface area; HTx, heart transplantation. Data are presented as mean ± SD or 
median (interquartile range) and n (%).
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4.3. Doppler Echocardiographic Indices
On Doppler examination, there were no significant 
differences among the patients with different ISHLT grades 
concerning mitral valve inflow and left and right ventricular 
MPIs (Table 3). The only parameter which was significantly 
different among the patients with different ISHLT grades 
was tricuspid E-wave velocity (P = 0.040). This measure 
of diastolic function was slightly lower in the patients with 
moderate ACAR compared to those with no or mild ACAR.
4.4. Mitral and Tricuspid Annular Motion Velocity Data
Pulsed-wave TDI revealed significant differences among 
the patients with no, mild, and moderate ACAR with regard 
to tricuspid annular early diastolic velocity (Em) (P = 0.019, 
Table 2. Conventional Echocardiographic Characteristics
ISHLT Grading 2005
P valueNo rejection (Grade 0) 
N = 39
Mild rejection (Grade 1R) 
N = 19
Moderate rejection (Grade 2R) 
N = 5
PWT (cm) 0.95 ± 0.12 0.94 ± 0.15 1.00 ± 0.18 0.751
IVST (cm) 0.96 ± 0.10 0.94 ± 0.12 0.94 ± 0.13 0.721
LVEDD (cm) 4.47 ± 0.54 4.38 ± 0.52 4.42 ± 0.46 0.871
LVESD (cm) 2.93 ± 0.62 2.73 ± 0.45 2.98 ± 0.123 0.392
LVEDV (mL) 75.21 ± 18.81 69.18 ± 17.79 66.84 ± 11.87 0.386
LVESV (mL) 31.45 ± 12.18 27.43 ± 7.44 28.34 ± 5.02 0.552
RAEDV (mL) 29.82 ± 13.17 27.94 ± 9.08 27.60 ± 14.67 0.988
RAESV (mL) 41.65 ± 16.86 41.08 ± 10.22 40.70 ± 23.11 0.966
LAEDV (mL) 38.96 ± 20.33 48.24 ± 29.15 50.25 ± 24.95 0.425
LAEDA (cm2) 15.59 ± 5.46 17.64 ± 7.36 18.132 ± 5.66 0.424
LV mass (gr) 144.39 ± 33.49 139.65 ± 43.68 146.16 ± 44.79 0.802
LVEF (%) 58.05 ± 8.85 59.57 ± 6.06 74.84 ± 4.14 0.448
RVFAS (%) 43.64 ± 7.65 44.94 ± 6.38 45.40 ± 6.26 0.976
RWMA Score Index 1.13 ± 0.27 1.07 ± 0.09 1.08 ± 0.07 0.769
TRG (mmHg) 27.5 ± 7.47 22.88 ± 5.67 23.60 ± 5.94 0.191
PAP (mmHg) 33.70 ± 8.15 28.82 ± 5.57 32.00 ± 7.61 0.181
TAPSE (mm) 17.11 ± 3.098 17.30 ± 3.27 17.40 ± 5.36 0.931
PE, n (%)
No 30 (76.9%) 14 (73.3%) 4 (80%)
0.723
Small 5 (12.8%) 5 (26.3%) 0 (0%)
Moderate 5 (5.1%) 0 (0%) 1 (20%)
Large 2 (5.1%) 0 (0%) 0 (0%)
Total 39 (100%) 19 (100%) 5 (100%)
Abbreviations: IVST, interventricular septum thickness; LAEDA, left atrialo end diastolic area; LAEDV, left atrial end diastolic 
volume; LV, left ventricle; LVEF, left ventricular ejection fraction; LVEDD, left ventricular end diastolic dimension; LVEDV, left 
ventricular end diastolic volume; LVESD, left ventricular end systolic dimension; LVESV, left ventricular end systolic volume; 
PAP, pulmonary artery pressure; PE, pericardial effusion; PWT, posterior wall thickness; RAEDV, right atrial end diastolic volume; 
RAESV, right atrial end systolic volume; RVFAS, right ventricular fractional area shortening; RWMA, regional wall motion 
abnormality; TAPSE, tricuspid annular plane systolic excursion; TRG, tricuspid regurgitation gradient
Data are presented as mean ± SD and n (%).
Table 3. Transmitral and Trans-Tricuspid Doppler Data
ISHLT Grading 2005
P valueNo rejection (Grade 0) 
N = 39
Mild rejection (Grade 1R)  
N = 19
Moderate rejection (Grade 2R) 
N = 5
Transmitral Doppler data
E-wave (m/s) 0.79 ± 0.19 0.83 ± 0.19 0.88 ± 0.21 0.625
A-wave (m/s) 0.45 ± 0.11 0.145 ± 0.09 0.45 ± 0.21 0.483
E to A ratio 1.83 ± 0.53 1.85 ± 0.35 2.13 ± 0.58 0.487
Time to E-wave (msec) 449.94 ± 37.33 445.72 ± 29.88 438.60 ± 51.88 0.681
Transtricuspid Doppler data
E-wave (m/s) 0.60 ± 0.18 0.70 ± 0.18 0.52 ± 0.10 0.040
A-wave (m/s) 0.49 ± 0.13 0.53 ± 0.15 0.55 ± 0.15 0.539
E to A ratio 1.28 ± 0.37 1.39 ± 0.36 0.95 ± 0.37 0.192
Time to E-wave (msec) 448.82 ± 33.82 438.52 ± 35.25 447.20 ± 66.57 0.505
Myocardial performance index
LV-MPI 0.41 ± 0.13 0.42 ± 0.11 0.36 ± 0.05 0.536
RV-MPI 0.38 ± 0.10 0.36 ± 0.11 0.38 ± 0.08 0.805
Abbreviations: LV, left ventricle; MPI, myocardial performance index; RV, right ventricle.
Data are presented as mean ± SD.
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Table 4). Moreover, significant differences were observed 
between the patients with and without allograft rejection 
concerning early diastolic tricuspid and mitral annular 
motion velocities (P = 0.005 and P = 0.024, respectively).
4.5. Color-Coded Tissue Doppler Imaging Data
Color-coded TDI study demonstrated significant 
differences among the patients with no, mild, and moderate 
ACAR regarding systolic velocity (Sm) and acceleration  rate 
of Sm (Sm-AR) of the basal segment of the right ventricular 
free wall (P = 0.011 and P = 0.017, respectively) (Table 5). 
Moreover, Em, Sm, and Sm-AR of the basal segment of 
the right ventricular lateral (free) wall were significantly 
higher in the patients with ACAR (grade ≥ 1R) compared to 
those without ACAR (P = 0.004, P = 0.021, and P = 0.007, 
respectively). The patients with various ACAR groups were 
also significantly different with respect to Em of the middle 
segment of the LV lateral wall (P = 0.017).
5. Discussion
Serial EMB is still the gold standard test for detection of 
cardiac allograft rejection. However, it is not convenient 
and has potential limitations and complications (3, 4). As 
a result, there has been increasing interest in defining 
alternative non-invasive diagnostic approaches.
Some investigators applied cardiac troponin (cTn) as an 
indicator of cardiac allograft rejection and almost failed 
to show any significant relationship between cTnT or 
cTnI levels and rejection grade (12-16). Mullen et al. also 
observed that cTn could not accurately show acute cardiac 
rejection over a mean follow-up of 129 ± 9 days (14). 
Several non-invasive techniques have also been evaluated 
in this regard, including radionuclide imaging, magnetic 
resonance imaging, intracardiac electrogram recording, 
and multiparametric immune monitoring (17-20). However, 
none of these non-invasive imaging techniques were found 
sufficiently reliable to replace EMB. Echocardiography 
has been in extensive use by cardiologists in the clinical 
surveillance of heart transplant recipients and almost all 
known echocardiographic studies have been on trials 
to determine whether they can predict acute allograft 
rejection. The first use of echocardiography to diagnose 
acute rejection is credited to Schroeder who demonstrated 
that acute rejection was associated with an increase in 
posterior LV wall thickness (21). This was further shown 
in other trials using M-mode echocardiography and 
measuring ventricular mass (22-25). Cardiac magnetic 
resonance imaging has also shown increased thickness 
of the LV septum, apex, and lateral walls in moderate 
transplant rejection (24).
Assuming a restrictive physiology due to myocardial 
infiltration, studies then applied echocardiographic indices 
to show whether restrictive physiology could predict 
allograft rejection. Putting all the data together, it seems 
that an apparent restrictive physiology is quite specific, but 
lacks sensitivity to moderate degree of allograft rejection 
since many recipients without rejection also showed 
restrictive physiology (26-30). However, we did not observe 
any significant restrictive physiology in our rejection cases. 
In addition to all the technical issues in measuring diastolic 
indices, we think early detection of cellular rejection on a 
routine EMB schedule should prevent the allograft from 
going into a severe restrictive state and, consequently, the 
related echocardiography indices should not be very useful.
In agreement with the previous studies, we also could 
not demonstrate any role for echocardiographic markers 
of systolic dysfunction (31). Although Paulsen et al. 
demonstrated that LVEF declined in patients with acute 
rejection (32), it is worth noting that decrease of EF in 
patients with less severe allograft rejection may be subtle 
enough to be neglected by echocardiographic examination.
MPI, combining systolic and diastolic function, is 
calculated as the sum of the Isovolumic Contraction Time 
(IVCT) and Isovolumic Relaxation Time (IVRT) divided 
by the ejection time. Burgess et al. (33) found an increase 
in IVCT and a decrease in IVRT during rejection with no 
significant change in the MPI. Vivekananthan et al. also 
showed that an MPI increase of ≥ 20% from baseline had 
90% sensitivity and 90% specificity in detecting high-
grade cardiac allograft rejection (34). This finding was not 
confirmed in other studies (35, 36). Similarly, we found no 
benefits in applying right and left ventricular myocardial 
Table 4. Pulse-Wave tissue Doppler Imaging Mitral and Tricuspid Annular Motion Velocity Data
ISHLT Grading 2005 P value
No rejection (Grade 0) 
N = 39
Mild rejection (Grade 1R)  
N = 19
Moderate rejection (Grade 2R) 
N = 5
RV Sm (m/s) 0.84 ± 0.25 0.95 ± 0.16 0.91 ± 0.22 0.242
Em (m/s) 0.77 ± 0.32 0.96 ± 0.26 1.02 ± 0.32 0.019
Am (m/s) 0.86 ± 0.35 0.79 ± 0.30 1.06 ± 0.54 0.643
E/Em ratio 8.93 ± 4.32 7.83 ± 2.95 5.60 ± 2.50 0.205
Septum Sm (m/s) 0.70 ± 0.18 0.73 ± 0.10 0.72 ± 0.16 0.784
Em (m/s) 0.82 ± 0.21 0.88 ± 0.21 0.80 ± 0.19 0.464
Am (m/s) 0.59 ± 0.18 0.53 ± 0.15 0.58 ± 0.16 0.556
E/Em ratio 10.20 ± 3.42 10.11 ± 3.38 11.75 ± 5.67 0.953
LV lateral Sm (m/s) 0.82 ± 0.26 0.89 ± 0.15 0.76 ± 0.13 0.143
Em (m/s) 1.20 ± 0.32 1.48 ± 0.36 1.33 ± 0.36 0.061
Am (m/s) 0.53 ± 0.24 0.53 ± 0.17 0.47 ± 0.14 0.911
E/Em ratio 7.05 ± 2.75 6.12 ± 1.89 7.00 ± 2.64 0.560
Abbreviations: Am, late diastolic velocity; Em, early diastolic velocity; LV, left ventricle; RV, right ventricle; Sm, systolic velocity.
Data are presented as mean ± SD.
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performance to predict allograft rejection.
TDI-derived indices have been shown to be useful in 
predicting subtle cardiac injuries when conventional indices 
of LV function are still normal. In a study conducted on 
nearly 400 biopsies using PW-TDI, significant allograft 
rejection (≥ grade 2) was shown to be associated with a 
significantly reduced peak early diastolic velocity (Em,) 
and a significantly prolonged early diastolic time (TEm) of 
the basal LV inferolateral wall (37). Three smaller studies 
have also demonstrated that Em significantly reduced in 
allograft rejection (23, 38, 39). On the other hand, other 
studies on 1500 biopsies in nearly 450 patients reported no 
association between acute allograft rejection and Em (40-46). 
Our study found that both tricuspid and mitral annular early 
(Em), but not late (Am), diastolic velocities were significantly 
different in the patients with acute allograft rejection. Stengel 
et al. (45) showed that Am and mitral annular systolic 
contraction velocity were higher in patients with higher 
degrees of rejection. Likewise, Kato et al. indicated that 
neither conventional echocardiographic indices nor Em or 
the E/Em mitral flow ratio could differentiate patients with 
and without allograft rejection (41).
In a study by Mankad et al., patients with biopsy-proven 
rejections had lower tissue Doppler posterior wall peak 
Table 5. Color-Coded Tissue Doppler Imaging Data
ISHLT Grading 2005
P valueNo rejection (Grade 0)  
N = 39
Mild rejection (Grade 1R) 
N = 19
Moderate rejection (Grade 2R) 
N = 5
RV-base Sm (cm/sec) 5.88 ± 2.37 8.13 ± 1.53 7.16 ± 2.58 0.011
Em (cm/sec) 5.75 ± 2.970 7.54 ± 1.98 7.33 ± 3.16 0.084
Am (cm/sec) 4.67 ± 2.62 4.51 ± 2.27 7.40 ± 4.04 0.320
Time of Sm (sec) 153.45 ± 31.48 154.06 ± 23.12 149.60 ± 51.23 0.831
Time to Em (msec) 456.34 ± 45.08 446.13 ± 31.61 438.40 ± 55.11 0.489
Sm-AR (cm/sec2) 39.50 ± 18.44 54.11 ± 14.00 53.29 ± 31.000 0.017
E-Em (sec) 28.77 ± 24.13 23.80 ± 24.01 19.60 ± 23.26 0.296
RV-middle Sm (cm/sec) 3.75 ± 1.70 4.74 ± 1.59 4.42 ± 2.95 0.232
Em (cm/sec) 2.96 ± 1.77 3.92 ± 1.73 3.89 ± 1.08 0.149
Am (cm/sec) 2.38 ± 1.55 2.43 ± 1.71 5.43 ± 2.95 0.150
Time of Sm (sec) 151.26 ± 34.88 152.66 ± 25.16 148.50 ± 61.90 0.861
Time to Em (msec) 466.48 ± 45.21 453.85 ± 45.86 417.25 ± 53.84 0.236
Sm-AR (cm/sec2) 25.47 ± 11.88 31.72 ± 14.21 37.38 ± 36.74 0.416
E-Em (sec) 37.56 ± 26.82 36.14 ± 19.80 40.50 ± 31.83 0.958
Septum-
base
Sm (cm/sec) 4.77 ± 1.40 5.10 ± 1.01 5.21 ± 0.50 0.321
Em (cm/sec) 6.26 ± 2.15 6.41 ± 1.64 6.79 ± 2.10 0.990
Am (cm/sec) 3.16 ± 1.36 3.10 ± 1.15 3.52 ± 1.82 0.800
Time of Sm (sec) 140.69 ± 28.24 142.56 ± 13.75 128.80 ± 28.18 0.624
Time to Em (msec) 458 ± 49.33 461.50 ± 33.91 45.40 ± 71.69 0.731
Sm-AR (cm/sec2) 35.13 ± 11.14 36.10 ± 7.70 42.08 ± 9.68 0.396
E-Em (sec) 29.30 ± 25.74 25.00 ± 13.77 20.00 ± 16.38 0.446
Septum-
middle
Sm (cm/sec) 2.41 ± 1.12 2.59 ± 0.75 2.75 ± 0.95 0.499
Em (cm/sec) 4.01 ± 1.55 4.25 ± 2.48 3.89 ± 2.99 0.898
Am (cm/sec) 1.56 ± 1.09 1.67 ± 0.89 1.48 ± 0.50 0.798
Time of Sm (sec) 143.45 ± 34.31 137.87 ± 17.53 115.80 ± 33.72 0.184
Time to Em (msec) 470.21 ± 53.00 466.62 ± 30.59 447.60 ± 77.46 0.534
Sm-AR (cm/sec2) 17.80 ± 8.40 19.19 ± 6.64 23.87 ± 6.62 0.259
E-Em (sec) 35.63 ± 25.51 26.46 ± 13.55 32.20 ± 16.60 0.518
LV lateral-
base
Sm (cm/sec) 6.39 ± 2.16 6.01 ± 1.91 5.45 ± 1.44 0.527
Em (cm/sec) 9.58 ± 2.52 10.40 ± 2.68 8.48 ± 4.61 0.636
Am (cm/sec) 2.93 ± 2.27 2.06 ± 1.61 2.08 ± 1.45 0.545
Time of Sm (sec) 150.77 ± 38.31 165.33 ± 46.55 165.80 ± 46.26 0.492
Time to Em (msec) 460.68 ± 32.48 451.53 ± 32.13 445.20 ± 63.93 0.442
Sm-AR (cm/sec2) 45.98 ± 22.32 39.65 ± 16.24 36.34 ± 17.42 0.610
E-Em (sec) 20.51 ± 16.44 19.28 ± 12.14 23.00 ± 15.48 1 
LV lateral-
middle
Sm (cm/sec) 4.41 ± 2.07 4.71 ± 1.77 3.91 ± 0.88 0.781
Em (cm/sec) 5.60 ± 2.12 7.61 ± 2.32 5.28 ± 2.80 0.016
Am (cm/sec) 2.02 ± 2.13 2.09 ± 1.48 1.65 ± 1.27 0.849
Time of Sm (sec) 154.08 ± 45.16 173.06 ± 49.69 168.80 ± 55.69 0.247
Time to Em (msec) 462.45 ± 39.65 450.13 ± 33.95 438.40 ± 65.39 0.324
Sm-AR (cm/sec2) 32.57 ± 39.65 30.18 ± 16.29 25.92 ± 12.38 0.860
E-Em (sec) 28.51 ± 21.66 20.00 ± 17.20 19.80 ± 12.26 0.192
Abbreviations: Am, late diastolic velocity; AR, acceleration rate; Em, early diastolic velocity; LV, left ventricle; RV, right ventricle; 
Sm, systolic velocity.
Data are presented as mean ± SD
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systolic and diastolic velocity gradients compared to those 
without rejection (38). They believed that although TDI 
could not differentiate rejection from other causes of low 
velocity values, high TDI velocity values could rule out 
rejection.
The present study results demonstrated higher early 
diastolic velocity (Em) of the basal segment of the right 
ventricular free wall in the patients with cardiac rejection. 
The results also showed that Em of the middle segment 
of the LV lateral wall was significantly different among 
various ACAR groups.
The major limitation of this study was its small sample 
size. Thus, the negative results obtained in this study 
might actually be a type II error. Another limitation of this 
study was that we did not assess the presence of antibody-
mediated rejection, which might have altered our results. 
The patchy and heterogeneous nature of the rejection 
process as well as the potential errors occurred during the 
biopsy might also have influenced our results.
Overall, the results of our study were not sufficient to 
suggest the use of echocardiographic parameters, even TDI-
derived indices, to replace surveillance EMB for detection 
of acute allograft rejection. Echocardiography indices are 
certainly helpful in allograft rejection patients, but the 
results should be always interpreted along with clinical and 
biopsy findings. Nonetheless, due to the potential benefits 
that non-invasive assessment of rejection could offer in 
heart transplant recipients, search for sensitive and specific 
non-invasive tools that can predict acute allograft rejection 
warrants to be continued by further prospective studies.
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